Hayat Pharmaceutical Industries Co. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 125.00% vs -61.54% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 250.00% vs -77.78% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.50",
          "val2": "2.00",
          "chgp": "125.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.10",
          "val2": "0.50",
          "chgp": "120.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.70",
          "val2": "0.20",
          "chgp": "250.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "164.40%",
          "val2": "70.00%",
          "chgp": "9.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.40% vs 5.70% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -25.81% vs 34.78% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.10",
          "val2": "16.70",
          "chgp": "2.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.70",
          "val2": "4.40",
          "chgp": "-15.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.30",
          "val2": "3.10",
          "chgp": "-25.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "140.30%",
          "val2": "192.10%",
          "chgp": "-5.18%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

4.50

2.00

125.00%

Operating Profit (PBDIT) excl Other Income

1.10

0.50

120.00%

Interest

0.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

0.70

0.20

250.00%

Operating Profit Margin (Excl OI)

164.40%

70.00%

9.44%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 125.00% vs -61.54% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 250.00% vs -77.78% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

17.10

16.70

2.40%

Operating Profit (PBDIT) excl Other Income

3.70

4.40

-15.91%

Interest

0.10

0.20

-50.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

2.30

3.10

-25.81%

Operating Profit Margin (Excl OI)

140.30%

192.10%

-5.18%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 2.40% vs 5.70% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -25.81% vs 34.78% in Dec 2024

All Annual Results